EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Amplitude Surgical's enterprise value is €215.9 Mil.
Amplitude Surgical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €21.2 Mil. Therefore, Amplitude Surgical's EV-to-EBITDA for today is 10.17.
The historical rank and industry rank for Amplitude Surgical's EV-to-EBITDA or its related term are showing as below:
XPAR:AMPLI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.39 Med: 12.55 Max: 41.73
Current: 10.17
During the past 13 years, the highest EV-to-EBITDA of Amplitude Surgical was 41.73. The lowest was 7.39. And the median was 12.55.
XPAR:AMPLI's EV-to-EBITDA is ranked better than 69.36% of 483
companies
in the Medical Devices & Instruments industry
Industry Median: 16.55
vs XPAR:AMPLI: 10.17
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Amplitude Surgical EV-to-EBITDA Historical Data
The historical data trend for Amplitude Surgical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Amplitude Surgical's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, Amplitude Surgical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplitude Surgical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Amplitude Surgical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Amplitude Surgical's EV-to-EBITDA falls into.
Amplitude Surgical's current Enterprise Value is €215.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Amplitude Surgical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €21.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Amplitude Surgical's PE Ratio for today is calculated as:
Amplitude Surgical's share price for today is €2.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Amplitude Surgical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.900.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Amplitude Surgical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Amplitude Surgical (XPAR:AMPLI) Business Description
Amplitude Surgical is engaged in developing and marketing products for orthopedic surgery. It offers a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities for foot and ankle surgery. The company also provides AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and the E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:AMPLI has been successfully added to your 